Alexandra Lee
1*
Rosemarie DeKruyff
1
Luisa Ricciardi
2The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Allergy
Sec. Therapies and Therapeutic Targets
Volume 5 - 2024 |
doi: 10.3389/falgy.2024.1448220
This article is part of the Research Topic The Safety, Efficacy and Effectiveness of Allergen-Specific Oral Immunotherapy View all 9 articles
Editorial: The Safety, E cacy, and E ectiveness of Allergen-Speci c Oral Immunotherapy
Provisionally accepted- 1 Stanford University, Stanford, United States
- 2 Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
Keywords: allergy, OIT, Sublinguaimmunotherapy, food allergy, Safety, efficacy
Received: 12 Jun 2024; Accepted: 16 Jul 2024.
Copyright: © 2024 Lee, DeKruyff and Ricciardi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Alexandra Lee, Stanford University, Stanford, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.